• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Find an Article (54922186)   Find a Category (126)   Find a Journal (6153)   Find a Scholar (4056)   Find an Academic Assistant (17)
Find an Article PDF (4584057)   Today's Articles (145)   Subscriber (49239)
Download
Total Articles

Ranked By
Results Analysis
  •   
  •   
  •   
  •   
Results Analysis
Year Published
Show more   Refine
Article Type
Show more   Refine
Article Statistics
Refine
MESH Headings
Show more   Refine
First Author
Show more   Refine
First Author Affiliations
Show more   Refine
Authors
Show more   Refine
Publication Titles
Show more   Refine
Grant Agencies
Show more   Refine
Countries/Regions
Show more   Refine
Affiliations
Show more   Refine
Corresponding Author Affiliations
Show more   Refine
Category
Show more   Refine
Number Citation Analysis
1
Bowles P, Brenek SJ, Caron S, Do NM, Drexler MT, Duan S, Dubé P, Hansen EC, Jones BP, Jones KN, Ljubicic TA, Makowski TW, Mustakis J, Nelson JD, Olivier M, Peng Z, Perfect HH, Place DW, Ragan JA, Salisbury JJ, Stanchina CL, Vanderplas BC, Webster ME, Weekly RM. Commercial Route Research and Development for SGLT2 Inhibitor Candidate Ertugliflozin. Org Process Res Dev 2014. [DOI: 10.1021/op4002802] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
2
Singer RA, Ragan JA, Bowles P, Chisowa E, Conway BG, Cordi EM, Leeman KR, Letendre LJ, Sieser JE, Sluggett GW, Stanchina CL, Strohmeyer H, Blunt J, Taylor S, Byrne C, Lynch D, Mullane S, O’Sullivan MM, Whelan M. Synthesis of Filibuvir. Part I. Diastereoselective Preparation of a β-Hydroxy Alkynyl Oxazolidinone and Conversion to a 6,6-Disubstituted 2H-Pyranone. Org Process Res Dev 2013. [DOI: 10.1021/op4002356] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
3
Ide ND, Ragan JA, Bellavance G, Brenek SJ, Cordi EM, Jensen GO, Jones KN, LaFrance D, Leeman KR, Letendre LJ, Place D, Stanchina CL, Sluggett GW, Strohmeyer H, Blunt J, Meldrum K, Taylor S, Byrne C, Lynch D, Mullane S, O’Sullivan MM, Whelan M. Synthesis of Filibuvir. Part III. Development of a Process for the Reductive Coupling of an Aldehyde and a β-Keto-lactone. Org Process Res Dev 2013. [DOI: 10.1021/op400237j] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
4
de Koning PD, McAndrew D, Moore R, Moses IB, Boyles DC, Kissick K, Stanchina CL, Cuthbertson T, Kamatani A, Rahman L, Rodriguez R, Urbina A, Sandoval (née Accacia) A, Rose PR. Fit-for-Purpose Development of the Enabling Route to Crizotinib (PF-02341066). Org Process Res Dev 2011. [DOI: 10.1021/op200131n] [Citation(s) in RCA: 72] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
5
Van Alsten JG, Reeder LM, Stanchina CL, Knoechel DJ. Continuous Reaction/Crystallization Process for Production of a Hazardous Intermediate. Org Process Res Dev 2008. [DOI: 10.1021/op800128g] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA